<DOC>
	<DOCNO>NCT01614080</DOCNO>
	<brief_summary>intravenous rt-PA effective reduce risk death dependency ischaemic stroke . This effect due early recanalization secondary lysis clot . However effect may counterbalance increase risk bleeding also neurotoxicity rt-PA , show animal depend ratio single chain ( sc ) / double chain ( tc ) rt-PA administer . The main objective OPHELIE determine whether functional outcome treatment iv rt-PA depends ratio sc-rtPA / tc-rtPA . Secondary objective identify influence risk brain haemorrhage , influence cognitive state ( OPHELIE-COG substudy ) .</brief_summary>
	<brief_title>Outcome Patients Treated iv Rt-PA Cerebral Ischaemia According Ratio Sc-tPA/Tc-tPA</brief_title>
	<detailed_description>OPHELIE multicenter study conduct France 25 center patient treat iv rt-PA include . Patients treat accord local protocol , without modification specifically study . A sample 2 drop rt-PA used treatment store analysis , determine sc-tPA/tc-tPA ration ( immunostaining ) . 700 patient need study assume difference 5 % find primary outcome measure ( modify Rankin scale 0-1 3 month ) alpha beta risk respectively 5 % 20 % . The participate clinical centre recruit altogether 500 patient per year thrombolysis . Assuming 70 % eligible , recruitment take less 2 year .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Brain Ischemia</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<mesh_term>Drug-Related Side Effects Adverse Reactions</mesh_term>
	<criteria>Being treat iv tPA acute cerebral ischaemia absence reliable informant rtPA leave syringe treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Stroke</keyword>
	<keyword>Ischemic stroke</keyword>
	<keyword>thrombolysis</keyword>
	<keyword>toxicity t-PA</keyword>
</DOC>